Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00471042 · ClinicalTrials.gov registry record
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
A clinical trial, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 30
- Enrollment target
NCT00471042: Completed study, sponsored by New York State Psychiatric Institute.
NCT00471042 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00471042 has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this treatment research study is to assess the effectiveness of buprenorphine maintenance treatment for opioid dependence delivered in a primary care clinic setting. This study will determine whether buprenorphine treatment in primary care is effective in reducing cravings, reducing illicit opioid use, reducing addiction severity, and retaining patients in primary care treatment for opioid dependence.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-06 |
| Est. Completion | 2012-08 |
What the finished NCT00471042 record still lists
NCT00471042 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00471042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00471042 about?
NCT00471042 is a clinical study titled "Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care". The purpose of this treatment research study is to assess the effectiveness of buprenorphine maintenance treatment for opioid dependence delivered in a primary care clinic setting. This study will determine whether buprenorphine treatment in primary care is effective in reducing cravings, reducing i...
What is the current status of trial NCT00471042?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00471042?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00471042?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia